Riskpilot← Back to searchSign inGet full accessVIRU ApS
APSActiveCVR 31895618Græshave Alle 26Research and experimental development on natural sciences and engineering · NACE 7210Est. 2008— employees
Revenue 2025
DKK 0
EBITDA margin
—
+60% vs 2024
Equity ratio
94.0%
Financial strength
Net profit 2025
DKK 106K
+108% vs 2024
| Revenue | DKK 0 | — |
| EBITDA | DKK -38K | +60% |
| Net profit | DKK 106K | +108% |
| Total assets | DKK 16,3M | +1% |
| Equity | DKK 15,4M | +1% |
| Employees | — | — |
Legal name
VIRU ApS
CVR number
31895618
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
18. december 2008
Share capital
DKK 125.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive virksomhed indenfor medicinalbranchen, branchen for naturlægemidler og hygiejneprodukter og enhver hermed beslægtet branche efter ledelsens skøn, herunder som holdingselskab.
Address
Græshave Alle 26
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | -12 | 0 | 0 | 0 | 0 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -12 | -64 | -17 | -95 | -38 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -12 | -64 | -17 | -95 | -38 |
| Net financials | 65 | 53 | 122 | 137 | 144 |
| Profit before tax | 54 | -11 | 105 | 43 | 106 |
| Tax | -0 | -0 | -0 | -8 | -0 |
| Net profit | 54 | -11 | 105 | 51 | 106 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 16.220 | 16.229 | 16.355 | 16.175 | 16.343 |
| Equity | 15.347 | 15.336 | 15.441 | 15.255 | 15.361 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 873 | 893 | 914 | 920 | 982 |
| Total debt | 873 | 893 | 914 | 920 | 982 |
EBITDA margin
-3841600.0%
This company
15.8%
Market median
-24314024% vs market
20212025
Equity ratio
94.0%
This company
38.2%
Market median
+146% vs market
20212025
Return on equity
0.7%
This company
18.4%
Market median
-96% vs market
20212025
Net profit margin
10564300.0%
This company
8.1%
Market median
+130423357% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 25–33.32% | 0% | 2008 | |
| Individual | 25–33.32% | 0% | 2008 | |
| Individual | 25–33.32% | 0% | 2008 | |
| Individual | 10–14.99% | 50–66.65% | 2008 | |
| Individual | 10–14.99% | 50–66.65% | 2008 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
VIRU ApS 
V-BIOTEK HOLDING ApSBoard members of VIRU ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|